Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Our U.S. Offices Are Closed

Our U.S. offices are closed in observance of Thanksgiving. We will reopen on Monday, December 1st.

Thank you for your patience.

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
eIF4A (C32B4) Rabbit mAb 2013 40 µl
Western Blotting
H M R Mk 48 Rabbit IgG
eIF4A1 Antibody 2490 40 µl
Western Blotting
H M R Mk 48 Rabbit 
Phospho-eIF4B (Ser422) Antibody 3591 40 µl
Western Blotting
H M R Mk 80 Rabbit 
eIF4B Antibody 3592 40 µl
Western Blotting
H M R Mk 80 Rabbit 
Phospho-eIF4E (Ser209) Antibody 9741 40 µl
Western Blotting
H M R Mk 25 Rabbit 
eIF4E (C46H6) Rabbit mAb 2067 40 µl
Western Blotting Immunoprecipitation Immunohistochemistry
H M R Mk 25 Rabbit IgG
Phospho-eIF4G (Ser1108) Antibody 2441 40 µl
Western Blotting Immunoprecipitation Immunofluorescence
H M R Hm Mk B 220 Rabbit 
eIF4G (C45A4) Rabbit mAb 2469 40 µl
Western Blotting Immunohistochemistry Immunofluorescence Flow Cytometry
H M R Mk 220 Rabbit 
eIF4H (D85F2) XP® Rabbit mAb 3469 40 µl
Western Blotting Immunoprecipitation Immunofluorescence
H M R Mk 25, 27 Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
All Goat 

Product Description

The Translation Initiation Complex Antibody Sampler Kit contains reagents to investigate the initiation of translation within the cell. The kit contains enough primary and secondary antibodies to perform four Western blot experiments per primary antibody.


Specificity / Sensitivity

Each antibody in the Translation Initiation Complex Antibody Sampler Kit detects endogenous levels of its target protein.


Source / Purification

Monoclonal antibodies are produced by immunizing animals with a synthetic petide corresponding to residues surrounding Met316 of human eIF4A protein, Gly188 of human eIF4G, and the sequence of human eIF4E and human eIF4H. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to a sequence around Gly12 of human eIF4A1, residues at the amino terminus of human eIF4B, Ser422 of human eIF4B, Ser209 of human eIF4E, and Ser1108 of human eIF4GI. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.

A variety of factors contribute to the important biological event of translation initiation. The Eukaryotic initiation Factor 4E (eIF4E) complex of translation initiation factors binds to the 5' m7 GTP cap to open up the mRNA secondary structure and allow small ribosome subunit binding (1). eIF4A, an eIF4 complex component that acts as an ATP-dependent RNA helicase, unwinds the secondary structure of the 5' mRNA untranslated region to mediate ribosome binding (2,3). EIF4E binds to the mRNA cap structure to mediate the initiation of translation (4,5). eIF4E interacts with eIF4G, a scaffold protein that promotes assembly of eIF4E and eIF4A into the eIF4F complex (5). eIF4B is thought to assist the eIF4F complex in translation initiation. eIF4H induces the RNA-dependent ATP hydrolysis catalyzed by the initiation factors eIF4A and eIF4B (2,6). eIF4H was further shown to determine the initial rate and extent of eIF4A-mediated mRNA secondary structure unwinding (7).


1.  Rogers, G.W. et al. (2001) J Biol Chem 276, 12598-608.

2.  Sonenberg, N. et al. (1978) Proc. Natl. Acad. Sci. USA 75, 4843-4847.

3.  Gingras, A. et al. (1999) Annu. Rev. Biochem. 68, 913-963.

4.  Rogers, G.W. et al. (1999) J Biol Chem 274, 12236-44.

5.  Svitkin, Y.V. et al. (2001) RNA 7, 382-94.

6.  Richter-Cook, N.J. et al. (1998) J Biol Chem 273, 7579-87.

7.  Rogers, G.W. et al. (2001) J Biol Chem 276, 30914-22.


Entrez-Gene Id 1973, 1974, 9775, 1975, 1977, 1981, 7458
Swiss-Prot Acc. P60842, Q14240, P38919, P23588, P06730, Q04637, Q15056


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 5,675,063.